Epidemiology and Treatment of Patients with Psoriasis (PSO) or Psoriatic Arthritis (PsA) in Germany

被引：0
|
作者：
Dombrowsky, W. [1 ]
Fabricius, V [1 ]
Grellmann, C. [2 ]
Suruki, R. [3 ]
Sheahan, A. [3 ]
Joeres, L. [1 ]
机构：
[1] UCB Pharma, Monheim, Germany
[2] Gesundheitsforen Leipzig GmbH, Leipzig, Germany
[3] UCB Pharma, Raleigh, NC USA
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2019年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P062
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [1] Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
    Grellmann, Claudia
    Dombrowsky, Wojciech
    Fabricius, Volker
    Suruki, Robert
    Sheahan, Anna
    Joeres, Lars
    [J]. ADVANCES IN THERAPY, 2021, 38 (01) : 366 - 385
  • [2] Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
    Claudia Grellmann
    Wojciech Dombrowsky
    Volker Fabricius
    Robert Suruki
    Anna Sheahan
    Lars Joeres
    [J]. Advances in Therapy, 2021, 38 : 366 - 385
  • [3] Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
    Shan-Shan Li
    Na Du
    Shi-Hao He
    Xu Liang
    Tian-Fang Li
    [J]. Rheumatology and Therapy, 2022, 9 : 1079 - 1090
  • [4] Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
    Li, Shan-Shan
    Du, Na
    He, Shi-Hao
    Liang, Xu
    Li, Tian-Fang
    [J]. RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1079 - 1090
  • [5] Clinical predictors for psoriatic arthritis (PsA) in patients with psoriasis
    Chandran, Vinod
    Toloza, Sergio M. A.
    Shanmugarajah, Sutha
    Pellet, Fawnda J.
    Schentag, Catherine T.
    Rosen, Cheryl T.
    Gladman, Dafina D.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S364 - S364
  • [6] PREVALENCE OF COMORBIDITES AMONG PATIENTS WITH PSORIASIS (PSO) WITH AND WITHOUT PSORIATIC ARTHRITIS (PSA) IN EUROPEAN UNION (EU)
    Narayanan, S.
    Franceschetti, A.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A41 - A41
  • [7] EPIDEMIOLOGY OF PSORIASIS AND PSORIATIC ARTHRITIS
    Cimmino, M. A.
    [J]. REUMATISMO, 2007, 59 : 19 - 24
  • [8] IMPACT OF LOW ADHERENCE ON COST-EFFECTIVENESS OF THE BIOLOGICAL TREATMENT OF PSORIASIS (PSO) AND PSORIATIC ARTHRITIS (PSA) IN SLOVENIA
    Hren, R.
    Milanic, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A558 - A558
  • [9] Can we predict psoriatic arthritis (PsA) in patients with psoriasis?
    Wilson, Floranne C.
    Icen, Murat
    Crowson, Cynthia S.
    McEvoy, Marian T.
    Gabriel, Sherine E.
    Kremers, Hilal Maradit
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4297 - 4297
  • [10] NEGATIVE CONTROL OUTCOMES (NCOs) TO ASSESS COMPARABILITY OF PSORIASIS (PsO) AND PSORIATIC ARTHRITIS (PsA) TREATMENTS
    Horner, M. E.
    Ogdie, A. R.
    Kent, S. T.
    Tran, K. T.
    Deignan, C.
    Cordey, M.
    Orroth, K. K.
    Brookhart, M. A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S5 - S5
12345